And even after the significant gains it has experienced in recent years, it might still be early enough to get on the ...

The global Analytical Standards Market , valued at USD 1.44 billion in 2022 , is projected to expand at a robust CAGR of 5.9% ...

Global companies have been hit with a brutal $320 billion in lost profit since 2017, and it has nothing to do with bad ...

Key Points CRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential ...

Trump’s budget proposal, from May, seeks to slash the Department of Health and Human Services’ budget by $31.3 billion ...

Almost 3,500 listed companies globally that have annual revenues above $1bn lost a combined $320bn in profit during periods of geopolitical and macro volatility, a study by EY-Parthenon, the strategy ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

Lab Africa co-located with IFAT Africa. 138 exhibitors from 12 countries at analytica Lab Africa Event reinforces global analytica trade show prominence Sustainability, digital transformation & ...

The global CHPTAC market is valued at USD 264 million in 2025 and is expected to reach USD 430 million by 2035. CHPTAC’s ...

According to Research by SNS Insider, U.S. Cancer Biomarkers Market to Surpass USD 22.70 Billion by 2032 Due to Rising Investment in Personalized Cancer Diagnostics.Austin, July 21, 2025 (GLOBE ...

Overview of Hepatitis C Drug MarketThe global Hepatitis C Drug Market is valued at USD 7.95 Billion in 2024 and is projected ...